Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 400

1.

Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men.

Laaksonen DE, Niskanen L, Punnonen K, Nyyssönen K, Tuomainen TP, Valkonen VP, Salonen R, Salonen JT.

Diabetes Care. 2004 May;27(5):1036-41.

PMID:
15111517
2.
3.
4.

Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome.

Niskanen L, Laaksonen DE, Punnonen K, Mustajoki P, Kaukua J, Rissanen A.

Diabetes Obes Metab. 2004 May;6(3):208-15.

PMID:
15056129
5.

Both total testosterone and sex hormone-binding globulin are independent risk factors for metabolic syndrome: results from Fangchenggang Area Male Health and Examination Survey in China.

Zhang J, Huang X, Liao M, Gao Y, Tan A, Yang X, Zhang H, Mo L, Zhang Y, Lu Z, Wu C, Hu Y, Mo Z.

Diabetes Metab Res Rev. 2013 Jul;29(5):391-7. doi: 10.1002/dmrr.2405.

PMID:
23463406
6.

The pituitary-gonadal axis and health in elderly men: a study of men born in 1913.

Tibblin G, Adlerberth A, Lindstedt G, Björntorp P.

Diabetes. 1996 Nov;45(11):1605-9.

PMID:
8866567
8.

Serum adiponectin confers little protection against diabetes and hypertension in Turkish men.

Onat A, Hergenç G, Can G, Küçükdurmaz Z.

Obesity (Silver Spring). 2009 Mar;17(3):564-70. doi: 10.1038/oby.2008.564. Epub 2008 Dec 18.

9.
10.

Associations of adiponectin with sex hormone-binding globulin levels in aging male and female populations.

Yasui T, Tomita J, Miyatani Y, Yamada M, Uemura H, Irahara M, Arai M, Kojimahara N, Okabe R, Ishii Y, Tashiro S, Sato H.

Clin Chim Acta. 2007 Nov-Dec;386(1-2):69-75. Epub 2007 Aug 14.

PMID:
17825805
11.

Total testosterone and sex hormone-binding globulin are associated with metabolic syndrome independent of age and body mass index in Korean men.

Hong D, Kim YS, Son ES, Kim KN, Kim BT, Lee DJ, Kim KM.

Maturitas. 2013 Feb;74(2):148-53. doi: 10.1016/j.maturitas.2012.10.016. Epub 2012 Dec 5.

PMID:
23218685
12.

The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer.

Nuver J, Smit AJ, Wolffenbuttel BH, Sluiter WJ, Hoekstra HJ, Sleijfer DT, Gietema JA.

J Clin Oncol. 2005 Jun 1;23(16):3718-25. Epub 2005 Feb 28.

PMID:
15738540
13.
14.

Testosterone, SHBG and risk of type 2 diabetes in the second evaluation of the Pizarra cohort study.

Soriguer F, Rubio-Martín E, Fernández D, Valdés S, García-Escobar E, Martín-Núñez GM, Esteva I, Almaraz MC, Rojo-Martínez G.

Eur J Clin Invest. 2012 Jan;42(1):79-85. doi: 10.1111/j.1365-2362.2011.02559.x. Epub 2011 Jun 16.

PMID:
21679181
15.

The role of sex hormone-binding globulin and testosterone in the risk of incident metabolic syndrome.

Haring R, Völzke H, Spielhagen C, Nauck M, Wallaschofski H.

Eur J Prev Cardiol. 2013 Dec;20(6):1061-8. doi: 10.1177/2047487312452965. Epub 2012 Jun 18.

PMID:
22711969
16.
17.

Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study.

Xu A, Tso AW, Cheung BM, Wang Y, Wat NM, Fong CH, Yeung DC, Janus ED, Sham PC, Lam KS.

Circulation. 2007 Mar 27;115(12):1537-43.

18.
19.

Relative androgen deficiency in relation to obesity and metabolic status in older men.

Chen RY, Wittert GA, Andrews GR.

Diabetes Obes Metab. 2006 Jul;8(4):429-35.

PMID:
16776750
20.

Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome.

Laaksonen DE, Lakka HM, Salonen JT, Niskanen LK, Rauramaa R, Lakka TA.

Diabetes Care. 2002 Sep;25(9):1612-8.

PMID:
12196436

Supplemental Content

Support Center